Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Tirzepatide is sold as Zepbound for chronic weight management and as Mounjaro for type 2 diabetes, working as a dual GLP-1/GIP receptor agonist that targets both the GLP-1 and GIP receptors instead of GLP-1 alone, which enhances fat metabolism and insulin sensitivity beyond a single-receptor peptide
Despite years of safe compounding, established protocols, and satisfied patients, Category 2 designation meant immediate cessation
IGF-1 LR3 has an extended half-life compared to native IGF-1, making it more effective at stimulating anabolic processes
Brown University Health Blog Team
For a complete overview of MOTS-c's mechanism and biology, see the MOTS-c peptide profile
US$ 22.49
US$ 22.91
US$ 20.63
US$ 26.61
US$ 27.15
US$ 26.30
US$ 29.84
US$ 22.77
